Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11603531 Methods and compositions for modulating splicing

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Skyhawk Therapeutics

0

Current Assignee

Skyhawk Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

March 14, 2023

0

Patent Application Number

175028240

Date Filed

October 15, 2021

0

Patent Citations

US Patent 10195196 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

US Patent 10196639 Modulation of gene expression and screening for deregulated protein expression

0

US Patent 10252984 Inhibiting G protein coupled receptor 6 kinase polypeptides

US Patent 10377742 AMPK-activating heterocyclic compounds and methods for using the same

0

US Patent 10358427 Modulators of indoleamine 2,3-dioxygenase

US Patent 10006027 Methods for modulating Ataxin 2 expression

US Patent 10053697 Programmable alternative splicing devices and uses thereof

US Patent 10076519 Substituted pyridazines as skeletal muscle modulators

...

Patent Primary Examiner

Kristin A Vajda

0

CPC Code

0

0

0

0

0

0

0

0

...

Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11603531 Methods and compositions for modulating splicing

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool